BLUE STAR FOODS CORP (BSFC)

US09606H3093 - Common Stock

0.1476  -0.14 (-48.21%)

After market: 0.1301 -0.02 (-11.86%)

Fundamental Rating

2

Overall BSFC gets a fundamental rating of 2 out of 10. We evaluated BSFC against 90 industry peers in the Food Products industry. Both the profitability and financial health of BSFC have multiple concerns. BSFC is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

BSFC had negative earnings in the past year.
In the past year BSFC has reported a negative cash flow from operations.
In the past 5 years BSFC always reported negative net income.
In multiple years BSFC reported negative operating cash flow during the last 5 years.

1.2 Ratios

BSFC has a Return On Assets of -62.30%. This is amonst the worse of the industry: BSFC underperforms 88.89% of its industry peers.
Looking at the Return On Equity, with a value of -103.34%, BSFC is doing worse than 82.22% of the companies in the same industry.
Industry RankSector Rank
ROA -62.3%
ROE -103.34%
ROIC N/A
ROA(3y)-79.62%
ROA(5y)-65.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BSFC has a worse Gross Margin (4.71%) than 87.78% of its industry peers.
BSFC's Gross Margin has declined in the last couple of years.
BSFC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.46%
GM growth 5Y-30%

More info and screens

3

2. Health

2.1 Basic Checks

BSFC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BSFC has more shares outstanding
Compared to 5 years ago, BSFC has more shares outstanding
BSFC has a better debt/assets ratio than last year.

2.2 Solvency

BSFC has an Altman-Z score of -7.08. This is a bad value and indicates that BSFC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.08, BSFC is doing worse than 88.89% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that BSFC is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, BSFC is doing good in the industry, outperforming 63.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -7.08
ROIC/WACCN/A
WACC17.46%

2.3 Liquidity

A Current Ratio of 1.86 indicates that BSFC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.86, BSFC is in line with its industry, outperforming 57.78% of the companies in the same industry.
BSFC has a Quick Ratio of 1.06. This is a normal value and indicates that BSFC is financially healthy and should not expect problems in meeting its short term obligations.
BSFC has a Quick ratio of 1.06. This is in the better half of the industry: BSFC outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.06

More info and screens

4

3. Growth

3.1 Past

BSFC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.23%, which is quite impressive.
The Revenue for BSFC has decreased by -17.30% in the past year. This is quite bad
BSFC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -28.23% yearly.
EPS 1Y (TTM)98.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.57%
Revenue 1Y (TTM)-17.3%
Revenue growth 3Y-24.28%
Revenue growth 5Y-28.23%
Sales Q2Q%-43.38%

3.2 Future

BSFC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.79% yearly.
The Revenue is expected to grow by 42.29% on average over the next years. This is a very strong growth
EPS Next Y112.5%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5Y12.79%
Revenue Next Year202.73%
Revenue Next 2Y42.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BSFC. In the last year negative earnings were reported.
Also next year BSFC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BSFC's earnings are expected to grow with 20.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y20.51%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BSFC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE STAR FOODS CORP

NASDAQ:BSFC (12/19/2024, 8:20:42 PM)

After market: 0.1301 -0.02 (-11.86%)

0.1476

-0.14 (-48.21%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)N/A N/A
Inst Owners0.83%
Inst Owner Change735.18%
Ins Owners20.87%
Ins Owner Change0%
Market Cap1.17M
Analysts82.86
Price Target20.4 (13721.14%)
Short Float %23.67%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-59.92%
Min Revenue beat(2)-67.04%
Max Revenue beat(2)-52.8%
Revenue beat(4)0
Avg Revenue beat(4)-64.39%
Min Revenue beat(4)-71.33%
Max Revenue beat(4)-52.8%
Revenue beat(8)0
Avg Revenue beat(8)-60.22%
Revenue beat(12)1
Avg Revenue beat(12)-53.56%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-6.5
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.75
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.3%
ROE -103.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.71%
FCFM N/A
ROA(3y)-79.62%
ROA(5y)-65.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.46%
GM growth 5Y-30%
F-Score4
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -496.72%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.06
Altman-Z -7.08
F-Score4
WACC17.46%
ROIC/WACCN/A
Cap/Depr(3y)1200.31%
Cap/Depr(5y)728.58%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.57%
EPS Next Y112.5%
EPS Next 2Y32.29%
EPS Next 3Y20.51%
EPS Next 5Y12.79%
Revenue 1Y (TTM)-17.3%
Revenue growth 3Y-24.28%
Revenue growth 5Y-28.23%
Sales Q2Q%-43.38%
Revenue Next Year202.73%
Revenue Next 2Y42.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year285.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.64%
OCF growth 3YN/A
OCF growth 5YN/A